Featured Research

from universities, journals, and other organizations

Malaria control to overcome disease’s spread as climate warms

Date:
May 19, 2010
Source:
University of Florida
Summary:
Contrary to a widespread assumption, global warming is unlikely to expand the range of malaria, according to a new study, because of malaria control, development and other factors that are at work to corral the disease.

Contrary to a widespread assumption, global warming is unlikely to expand the range of malaria because of malaria control, development and other factors that are at work to corral the disease.

So concludes a team of scientists including two University of Florida researchers in a paper appearing May 20 in the journal Nature.

Scientists and public policy makers have been concerned that warming temperatures would create conditions that would either push malaria into new areas or make it worse in existing ones. But the team of six scientists, including David Smith and Andy Tatem, faculty members with UF's biology and geography departments and both at UF's Emerging Pathogens Institute, analyzed a historical contraction of the geographic range and general reduction in the intensity of malaria -- a contraction that occurred over a century during which the globe warmed. They determined that if the future trends are like past ones, the contraction is likely to continue under the most likely warming scenarios.

"If we continue to fund malaria control, we can certainly be prepared to counteract the risk that warming could expand the global distribution of malaria," Smith said.

The team, part of the Wellcome Trust's multinational Malaria Atlas Project, noted that malaria control efforts over the past century have shrunk the prevalence of the disease from most of the world to a region including Sub-Saharan Africa, Southeast Asia and South America, with the bulk of fatalities confined to Africa. This has occurred despite a global temperature rise of about 1 degree Fahrenheit, on average, during the same period.

"The globe warmed over the past century, but the range of malaria contracted substantially," Tatem said. "Warming isn't the only factor that affects malaria."

The reasons why malaria has shrunk are varied and in some countries mysterious, but they usually include mosquito control efforts, better access to health care, urbanization and economic development. The banned pesticide DDT was instrumental in ridding the disease from 24 countries in Southern Europe, the former Soviet Union and elsewhere in the world between 1955 and 1969, Smith said. Researchers debate how the U.S. defeated malaria, but the reduction of mosquito breeding grounds, improved housing and reduced emphasis on agriculture that comes with development -- and the reduced risk of bites that accompanies urbanization -- probably played a role, Smith said.

"There is no one tale that seems to determine the story globally," Tatem said. "If we had to choose one thing, we would guess economic development, but that's kind of a cop out" because the specific mechanisms may still remain unclear, and controlling malaria might also help to kick-start development.

In any case, current malaria control efforts such as insecticide-treated bed nets, modern low-cost diagnostic kits and new anti-malarial drugs, have proved remarkably effective, with more and more countries achieving control or outright elimination. Unless current control efforts were to suddenly stop, they are likely to counteract the spread of mosquitoes or other malaria-spreading effects from anticipated temperature increases, Smith said.

Simon Hay, an author of the Nature paper and one of the chief architects of the Malaria Atlas Project, noted that modern malaria control efforts "reduce transmission massively and counteract the much smaller effects of rising temperatures."

"Malaria remains a huge public health problem, and the international community has an unprecedented opportunity to relieve this burden with existing interventions," he said. "Any failure in meeting this challenge will be very difficult to attribute to climate change."


Story Source:

The above story is based on materials provided by University of Florida. The original article was written by Aaron Hoover. Note: Materials may be edited for content and length.


Journal Reference:

  1. Peter W. Gething, David L. Smith, Anand P. Patil, Andrew J. Tatem, Robert W. Snow, Simon I. Hay. Climate change and the global malaria recession. Nature, 2010; 465 (7296): 342 DOI: 10.1038/nature09098

Cite This Page:

University of Florida. "Malaria control to overcome disease’s spread as climate warms." ScienceDaily. ScienceDaily, 19 May 2010. <www.sciencedaily.com/releases/2010/05/100519143413.htm>.
University of Florida. (2010, May 19). Malaria control to overcome disease’s spread as climate warms. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/05/100519143413.htm
University of Florida. "Malaria control to overcome disease’s spread as climate warms." ScienceDaily. www.sciencedaily.com/releases/2010/05/100519143413.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins